All articles tagged with #oura
Smart ring maker Oura postponed its initial public offering, citing market uncertainty, while AI wearables face growing public backlash over privacy. Meta’s smart glasses have been criticized as surveillance tools, and analysts question if the technology’s utility outweighs consumer apprehension. The delay coincides with a broader trend of AI companies facing regulatory and public scrutiny.
Smart-ring maker Oura postponed its initial public offering on Tuesday, citing uncertainty in the market. This move follows delays by Holtec International and Bamboo Insurance, while AI firm Anthropic proceeds with its listing. The divergence highlights a narrow market where only AI-linked companies are attracting investor interest.
Oura has delayed its planned initial public offering, which would have valued the smart-ring maker at $15 billion, citing uncertainty in the IPO market. The company had filed for a Nasdaq listing just over a week ago, aiming to raise up to $2.2 billion. This move follows a wave of similar postponements by other tech and energy firms, reflecting broader investor caution due to rising bond yields and macroeconomic instability. While Oura’s CEO Tom Hale stated the company is choosing its moment for a public debut, the delay occurs despite strong revenue growth and a recent class action lawsuit over sleep-tracking accuracy claims.
Oura has withdrawn its plans for a US stock market listing that would have valued the company at $15 billion, citing uncertainty in the IPO market. The decision follows a wave of similar postponements by other firms, driven by rising bond yields and macroeconomic instability. While Oura faces specific scrutiny over its narrow product line, analysts note that broader market conditions and the availability of private capital are making public listings less attractive for many companies.
Oura Inc has postponed its planned initial public offering due to market uncertainty, despite strong demand and a projected 90% revenue increase. The company, which aims to monitor health via smart rings, had targeted a $13.5 billion valuation. This decision follows a weak third quarter for IPOs, driven by concerns over AI spending, rising bond yields, and Federal Reserve rate hikes.
Oura has postponed its planned Nasdaq listing, citing market uncertainty despite strong business growth. The company had launched its IPO process on September 21, aiming to raise up to $2.2 billion. CEO Tom Hale stated the company is choosing its moment for a public debut. This delay follows similar moves by other firms like Holtec Nuclear, reflecting broader investor caution.
Rumors say Apple Watch Series 12 with watchOS 27 will introduce a Readiness app (a variant of the Vitals app) to rival Oura and Whoop by providing daily readiness estimates from overnight metrics; reports also hint at 128GB storage and new sensors, though user reaction on social media is mixed.
Oura has filed to go public as rivals pile into the smart-ring space. The Finnish company says revenue reached about $1.21 billion for the nine months through June, with roughly 3.6 million rings sold in the last year and around 5 million paid members. As Oura rolls out the Ring 5, competitors such as Ultrahuman (Ring Pro), Circular (Ring 3), RingConn Gen 3, Samsung’s Galaxy Ring and Dreame are adding features like NFC payments, haptics, on‑device processing and ECG, signaling a shift from passive health tracking to a smartphone‑like experience on a tiny titanium band.
Oura, the Finnish health-tracking smart-ring maker, filed to list on Nasdaq, signaling investor interest after reporting $1.21bn in revenue for the nine months to June (up 74% YoY) and its first yearly profit, followed by $60.8m in the nine months to June. Its after-sales subscription business has grown to about 5 million users with 89% gross margins, producing $240.5m in membership revenue (up 121%), while hardware accounts for roughly 80% of sales. Ring 5 launched in May at $399, the app is opened about 3.5 times daily, and the user base is 72% female, with 42bn hours of biometric data collected across 50 metrics.
A San Francisco class-action alleges Oura’s $300 ring misleads consumers about its ability to track sleep and identify sleep stages, arguing that finger-based data and AI estimates cannot match clinical sleep studies. The suit cites claimed accuracies of 79% and 95% for sleep-staging and seeks injunctions plus restitution for buyers; Oura has not commented.
A California proposed class action accuses Oura of overstating the accuracy of its sleep-tracking, arguing the sleep-stage results rely on AI estimates based on finger signals rather than clinical sleep-staging sensors and that some results have little more than a coin flip’s chance of being correct. The suit cites a 2025 study showing 53.18% sleep-stage accuracy, contrasts with Oura’s prior 79% and 95% claims, and seeks to stop the misleading claims and restitution for affected customers, naming Oura Ring 5, Ring 4, and Ring 4 Ceramic.
A California class-action alleges Oura Ring overstated its ability to measure sleep quality and stages, arguing that sleep occurs in the brain and cannot be accurately read from a finger sensor; the suit seeks to halt alleged deceptive advertising and restitution for buyers who paid hundreds for the device, while Oura defends its methodology and cites supporting studies, highlighting ongoing scrutiny of wearable sleep trackers in a multibillion-dollar market.
Oura unveils Ring 5, the smallest smart ring yet—40% smaller than Ring 4 with longer battery life and a 2.28mm profile—focused on sleep, stress, readiness and heart health; priced from £399 and shipping June 4 with a £5.99/month subscription. Ahead of an IPO later this year, Oura has about 5 million paying subscribers, $1 billion in revenue in 2025, and an $11 billion valuation, with expanded software features like health radar and GLP-1 tracking alongside widespread sports and health partnerships.
Apple’s 11-year-old Watch is losing momentum as rivals Whoop, Oura, and Google-backed Fitbit Air push screenless health tracking focused on recovery and sleep. Leadership churn at Apple—retirements and exits across health, hardware, and marketing—amid a push to simplify Health and pursue AI-driven services. Oura’s confidential IPO filing signals competitive pressure, while Apple’s Health app remains cluttered and less actionable. watchOS 27 will be incremental, with heart-rate improvements and AI features drifting into iOS 27 more broadly, and a glucose-monitoring project—once a Jobs-era ambition—still progress-laden. The market is expanding beyond wrists toward glasses and other devices, pressuring Apple to decide whether to lead a screenless, AI-powered health era or risk falling behind.
Renders allegedly from Android Headlines show the Oura Ring 5 with a new ‘deep rose’ color (replacing rose gold) alongside black, silver, and gold options, plus a matte ‘stealth’ black variant. The design appears slightly rounder with a sharper curve, the charging case and pedestal look unchanged, and battery life staying in the 5–8 day range. Potential new features may come from Oura’s Doublepoint gesture-recognition startup, hinting at future AI-driven interactions.